Used for: Overactive bladder, allergies, depression, Parkinson's, COPD
This is the most concerning category—and the one many people don't know they're taking.
What the research shows:
A 2025 Swedish nationwide study found that strong anticholinergics were associated with a dose-dependent increase in dementia risk:
| Cumulative Use | Increased Risk |
|---|---|
| 1-89 days | 10% higher risk |
| 1-3 years | 49% higher risk |
| 3+ years | 66% higher risk |
Another 2025 study of over 217,000 participants found that any use of anticholinergic medications was associated with a 6-15% increased dementia risk, depending on the cohort.
Common anticholinergic drugs to watch:
Oxybutynin (Ditropan) – overactive bladder
Diphenhydramine (Benadryl, Tylenol PM, Advil PM) – allergies, sleep
Amitriptyline, nortriptyline – depression, nerve pain
Hydroxyzine (Atarax, Vistaril) – anxiety, allergies
Cyclobenzaprine (Flexeril) – muscle spasms
What to do: Request a medication review with your doctor. Many conditions have non-anticholinergic alternatives (see safer options below).
😴 3. Sleep Medications (OTC and Prescription)
Used for: Insomnia
What the research shows:
A 15-year study published in the Journal of Alzheimer's Disease found that people who reported taking sleep medications "often or almost always" had a significantly increased risk of developing dementia.
Specific medications studied included:
Antihistamines (diphenhydramine, doxylamine)
Trazodone
Zolpidem (Ambien)
Benzodiazepines (temazepam, estazolam)
Certain antidepressants with sedating effects
What to do: Try non-medication approaches first: consistent bedtime routines, avoiding caffeine/alcohol before bed, limiting naps, and cognitive behavioral therapy for insomnia (CBT-I), which has strong efficacy without medication risks.
💔 4. Antidepressants (Certain Types)
Used for: Depression, anxiety, nerve pain
What the research shows:
The Swedish nationwide study identified certain antidepressants among the strong anticholinergic medications associated with increased dementia risk. Specifically:
Amitriptyline
Nortriptyline
Paroxetine (unique among SSRIs for its anticholinergic effects)
Doxepin (especially at higher doses)
Important nuance: Not all antidepressants carry this risk. SSRIs like sertraline (Zoloft) , citalopram (Celexa) , and escitalopram (Lexapro) have lower anticholinergic burden.
What to do: Don't stop your antidepressant abruptly. If you're concerned, ask your doctor about switching to a lower-risk option.
🫀 5. Proton Pump Inhibitors (Prilosec, Nexium, Prevacid)
Used for: Acid reflux, GERD, heartburn
What the research shows:
A 2025 Mendelian randomization study found that lansoprazole was associated with a significantly increased risk of Alzheimer's disease and all-cause dementia. Another common PPI, omeprazole, showed mixed results—increased risk for frontotemporal dementia but possible protective effects for vascular dementia.
What to do: PPIs are often overprescribed and used for longer than necessary. Ask your doctor if you still need them, or if you can try:
Lower doses
"On-demand" use (only when symptoms occur)
H2 blockers (famotidine/Pepcid) which may have lower risk
Lifestyle changes (elevating head of bed, avoiding late meals)
💧 6. Overactive Bladder Medications
Used for: Urgency, frequency, incontinence
What the research shows:
The Swedish study found that urinary antispasmodics were among the drug classes most strongly associated with dementia risk. These include:
Oxybutynin (Ditropan) – highest risk
Tolterodine (Detrol)
Solifenacin (Vesicare)
Trospium
What to do: Ask about newer overactive bladder medications like mirabegron (Myrbetriq) , which works through a different mechanism and does not have anticholinergic effects. Non-drug options include pelvic floor therapy and bladder training.
🤧 7. First-Generation Antihistamines (Benadryl, Chlor-Trimeton)
Used for: Allergies, colds, sleep, itching
What the research shows:
These older antihistamines cross the blood-brain barrier and block acetylcholine in the brain. Studies consistently link long-term use to cognitive decline.
Examples:
Diphenhydramine (Benadryl, Tylenol PM, ZzzQuil, Advil PM)
Chlorpheniramine (Chlor-Trimeton)
Hydroxyzine (Atarax, Vistaril)
Doxylamine (Unisom, NyQuil)
What to do: For allergies, switch to second-generation antihistamines like cetirizine (Zyrtec) , loratadine (Claritin) , or fexofenadine (Allegra) , which do not cross the blood-brain barrier as readily. For sleep, try non-pharmacological approaches first.
🧠8. Statins (Controversial—Read This Carefully)
Used for: High cholesterol, heart disease prevention
This is the most debated category—and the evidence has shifted significantly.
What the research shows:
A 2015 meta-analysis of 23 randomized controlled trials (29,012 participants) found no significant adverse effects of statins on cognition in either cognitively normal subjects or those with Alzheimer's disease.
The FDA's 2012 warning about cognitive side effects was based primarily on case reports and post-marketing surveillance—not randomized controlled trials. The meta-analysis authors concluded that the FDA warning "may no longer be warranted".
The bottom line: For most people, the cardiovascular benefits of statins (preventing heart attack and stroke) far outweigh any potential cognitive risks. Don't stop your statin due to dementia fears without talking to your doctor—the proven benefits are substantial.
What to do: If you notice cognitive changes after starting a statin, discuss it with your doctor. They may consider switching to a different statin (lipophilic statins like atorvastatin cross the blood-brain barrier more than hydrophilic statins like pravastatin). But don't stop on your own.
📊 Risk Summary Table
✅ Safer Alternatives (Discuss with Your Doctor)
| Condition | Safer Options |
|---|---|
| Anxiety | CBT, SSRIs (sertraline, escitalopram) |
| Insomnia | CBT-I, sleep hygiene, melatonin, trazodone (short-term) |
| Allergies | Second-gen antihistamines (Zyrtec, Claritin, Allegra), nasal steroids |
| Overactive bladder | Mirabegron (Myrbetriq), pelvic floor therapy, bladder training |
| Depression | SSRIs with low anticholinergic burden (sertraline, citalopram, escitalopram) |
| GERD/Acid reflux | H2 blockers (famotidine), lifestyle changes, lower-dose PPI as needed |
| Muscle spasms | Physical therapy, NSAIDs, alternative muscle relaxants |
🩺 What to Do Next
1. Don't stop any medication abruptly. Withdrawal from benzodiazepines, antidepressants, or other medications can be dangerous.
2. Request a medication review. Ask your doctor or pharmacist: "Are any of my medications strongly anticholinergic? Are there safer alternatives?"
3. Use the lowest effective dose for the shortest necessary duration. This is especially important for benzodiazepines and sleep aids.
4. Ask about deprescribing. If you've been on certain medications for years, you may be able to taper off safely.
5. Focus on non-drug approaches first. For insomnia, anxiety, and mild depression, behavioral interventions are often as effective as medication—without the risks.
6. Know the signs of dementia. Early detection matters. If you or a loved one notice memory changes, discuss them with your doctor—but don't automatically blame medications without investigation.
🔑 The Bottom Line
Several common medications—especially strong anticholinergics, benzodiazepines, and certain sleep aids—have been linked to increased dementia risk, particularly with long-term, high-dose use.
However: Association is not causation. Many studies have limitations, and for many people, the benefits of these medications outweigh potential risks.
The best approach:
Have an open conversation with your doctor
Review your medications regularly (especially if you're over 65)
Ask about safer alternatives
Never stop medications abruptly
Your brain health matters—but so does treating the conditions these medications address. The goal isn't fear. It's informed, shared decision-making.
